Zydus To Join Trials For COVID-19

Zydus Cadila on Monday said it could soon start a trial to see the effectiveness of pegylated interferon-alpha-2b as a treatment for Covid-19, joining the global effort to find a way to stop the spread of SARS-CoV-2, the virus that causes the disease.

Ahmedabad-based Zydus has initiated talks with the Department of Biotechnology for a compassionate trial. It is also working with the USFDA to register the drug for “compassionate use programme”